Cronos Group Reports Record Financial Results for Q2 2026
Cronos Group Inc., the cannabis industry leader trading on NASDAQ and TSX under the ticker symbol CRON, delivered outstanding financial performance in the second quarter of 2026. The company recorded a remarkable net revenue of $53.0 million, a 51% increase compared to the same quarter in 2025, when adjusted for constant currency and organic growth. This growth was primarily driven by increased cannabis flower sales in Israel and Germany, which are not subject to excise taxes, and robust sales in Canada. The company also benefited from the strengthening of the New Israeli Shekel versus the U.S. dollar, contributing to the revenue increase.
The substantial rise in revenue was primarily attributed to a surge in cannabis flower sales across Israel and Germany, both of which do not impose excise taxes, along with strong growth in Canada. The performance in these regions, especially in Germany, fueled the overall revenue increase. In addition to higher sales, Cronos achieved a gross profit of $28.5 million, which saw a $13.9 million gain over the previous year’s second quarter. The higher volumes improved efficiency by spreading fixed overhead costs over greater production, contributing to the gross margin improvement.
Profitability Turnaround
Cronos experienced a significant turnaround in profitability, reporting a net income of $35.7 million in Q2 2026, a striking change from the $38.5 million net loss recorded in the same period in 2025. Adjusted EBITDA also witnessed a major improvement, climbing to $13.1 million, an increase of $11.4 million from the second quarter of the prior year. The improvement in both net income and Adjusted EBITDA was primarily driven by the higher gross profit, partially offset by increased operating expenses, including higher costs related to sales and marketing, general and administrative functions, and research and development. These expenses were a natural consequence of the company’s growth and strategic initiatives aimed at expanding market presence and launching new products.
In the Canadian market, the Spinach® brand continued to dominate, maintaining its top position in vapes and edibles for multiple consecutive quarters. The brand expanded its presence in vapes, gaining market share and remaining the leading choice in edibles. Specifically, Spinach® maintained its position as Canada’s #1 edible brand for the eighth consecutive quarter with a market share of 20.8%. The brand also held the top position in vapes for the second consecutive quarter, with market share expanding to 10.6% across all formats. Within vape cartridges specifically, Spinach® held the #1 position for the third consecutive quarter, capturing 11.8% market share. Notably, five of the top 10 edibles SKUs in Canada were Spinach® products, including the Fully Blasted Blue Raspberry Watermelon 10 Pack, which was the top-selling edibles product nationally.
Israel Market Success
Cronos Israel continued to set new records, achieving its tenth consecutive quarter of record net revenue. The company also took active steps to strengthen shareholder value through a robust share repurchase program, acquiring 12.3 million shares in the first half of 2026. This move signals strong confidence in the company’s future and its stock. Cronos Israel’s performance was driven by the continued dominance of the PEACE NATURALS® brand, which remains the leading cannabis brand in Israel. In addition to Israel, the international business, led by momentum in Germany, delivered record net revenue, with PEACE NATURALS® contributing significantly to the international growth.
During the quarter, Cronos expanded its product offerings in Canada by launching three new PUFFERZ™ vape flavors: Strawberry Burst, Peach Iced Tea, and Grape Gas. These additions significantly enriched the brand’s all-in-one vape portfolio, offering consumers more options. The company also saw strong performance in flower strains, with two Spinach® products among the top six-selling flower items in the nation. Spinach® remained the #3 brand in flower in Canada, with market share expanding to 5.4%, as GMO Cookies and OG Kush ranked among the top six nationally.
Leadership and Strategy
Mike Gorenstein, Cronos’ Chairman, President, and CEO, emphasized the company’s disciplined approach to executing its strategic priorities. He highlighted the company’s ability to grow, reinvest, and return value to shareholders, citing Cronos’ strong financial position as a key factor in this success. He reiterated the company’s commitment to its share repurchase program, stating that it represents an attractive use of capital, given the company’s industry-leading balance sheet and positive cash flow from operations.
Cronos remains flexible and prepared to seize opportunities as they emerge in the evolving cannabis market. With a focus on both innovation and operational efficiency, the company is well-positioned for sustained success. Gorenstein noted that Cronos is not only focused on growth but also on returning capital to shareholders while maintaining optionality to capitalize on attractive opportunities that may arise.